Company / R&D per Share
MBX Biosciences, Inc. R&D per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.39
FY2024
5-year range
$5.39 / $28.01
FY2023-FY2024
Trend
-80.7%
vs FY2023
Sector context
#31 of 208
Health Care
What the data says
MBX Biosciences, Inc.'s r&d per share of $5.39 is higher than 85% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
5.39 in FY2024. Top quartile in the Health Care sector.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 208This company $5.39 Sector average $28.82
▼
-81.3% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 80.7% year-over-year.
- Ranks #31 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.39 | -80.7% |
| FY2023 | $28.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026